• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

September 29, 2017

Trending News Today: PCSK9 Inhibitors Remain Out of Reach for Many Patients

Author(s):

Laurie Toich, Assistant Editor

Top news of the day from across the healthcare landscape.

A new study found that less than one-third of patients prescribed PCSK9 inhibitors are able to start treatment due to high out-of-pocket costs, according to Kaiser Health News. Although the new cholesterol drugs are extremely effective, they can cost up to $14,000 per year, which has caused payers to implement pre-approval requirements. The study found that only 47.2% of patients prescribed 2 of the drugs were able to receive pre-approval, while two-thirds of those patients were able to fill the prescription, according to the article.

Massachusetts is seeking to control Medicaid costs by limiting the number of drugs covered by the program, according to Stat. State officials said that they should be able to use cost-containment strategies similar to those used by commercial insurers to ensure that they can provide adequate care for all Medicaid beneficiaries. Due to rising drug costs, officials are concerned that if drug coverage is not limited, they may be forced to cut spending on crucial programs, according to the article. The Medicaid program currently covers all prescription drugs.

A single genetic mutation resulted in the Zika virus becoming a serious problem in pregnant women and resulted in a public health crisis, the Los Angeles Times reported. When Zika was first discovered in 1947, it made humans mildly ill, a far cry from the thousands of microcephaly cases and other birth defects seen in more recent years. Scientists discovered that a mutation in May 2013 resulted in more pronounced health effects and disabilities, highlighting the harmful potential of all viruses, according to the study.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
3 experts are featured in this series.
Related Content
Advertisement
Tremelimumab–Durvalumab Combo Extends Survival and Improves Cost-Effectiveness Over Sorafenib in Unresectable HCC
August 17th 2025

Tremelimumab–Durvalumab Combo Extends Survival and Improves Cost-Effectiveness Over Sorafenib in Unresectable HCC

Benjamin Gibson, PharmD, PAHM
A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025
August 17th 2025

A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
A Pharmacist’s Guide to New IDSA Guidelines for Complicated UTIs
August 17th 2025

A Pharmacist’s Guide to New IDSA Guidelines for Complicated UTIs

Amy C. Nieto, BS, PharmD Candidate
Pharmacy Times, Pharmacy Focus Oncology Edition
August 17th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
BPD, bipolar or schizophrenia disorder mind mental. Mental health. Borderline personality disorder. Psychology concept mood disorder with head silhouette.
August 17th 2025

Novel Prescription Digital Therapeutic Improves Negative Symptoms of Schizophrenia

Luke Halpern, Assistant Editor
Tenapanor in Hyperphosphatemia Is Effective but Has Cost, Market Barriers
August 17th 2025

Tenapanor in Hyperphosphatemia Is Effective but Has Cost, Market Barriers

Joanne Pauyo, PharmD, MBA, BCMTMs
Related Content
Advertisement
Tremelimumab–Durvalumab Combo Extends Survival and Improves Cost-Effectiveness Over Sorafenib in Unresectable HCC
August 17th 2025

Tremelimumab–Durvalumab Combo Extends Survival and Improves Cost-Effectiveness Over Sorafenib in Unresectable HCC

Benjamin Gibson, PharmD, PAHM
A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025
August 17th 2025

A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
A Pharmacist’s Guide to New IDSA Guidelines for Complicated UTIs
August 17th 2025

A Pharmacist’s Guide to New IDSA Guidelines for Complicated UTIs

Amy C. Nieto, BS, PharmD Candidate
Pharmacy Times, Pharmacy Focus Oncology Edition
August 17th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
BPD, bipolar or schizophrenia disorder mind mental. Mental health. Borderline personality disorder. Psychology concept mood disorder with head silhouette.
August 17th 2025

Novel Prescription Digital Therapeutic Improves Negative Symptoms of Schizophrenia

Luke Halpern, Assistant Editor
Tenapanor in Hyperphosphatemia Is Effective but Has Cost, Market Barriers
August 17th 2025

Tenapanor in Hyperphosphatemia Is Effective but Has Cost, Market Barriers

Joanne Pauyo, PharmD, MBA, BCMTMs
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.